Webinarnachlese – Pembrolizumab & Lenvatinib in der Praxis

MSD-Airport-Headerbanne
MSD-Airport-Subbanners-Urogenital_tcm5313-1306449
Zurück zu GU
07_2022_GU_Landingpage_Thumbnail
PDF downloaden

Related Content

ONKO Newsroom

4 Jahres-Follow up Daten CLEAR / KN-581¹

06_2022_GU_Thumbnail_300x300
ONKO Newsroom

ASCO 2022 – Neues zum lokalisierten Nierenzellkarzinom (RCC)

07_2022_GU_Landingpage_Thumbnail
ONKO Newsroom

Webinarnachlese – Pembrolizumab & Lenvatinib in der Praxis